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Aims Studies indicate a poorer quality of life (QoL) for implantable cardioverter defibrillator (ICD)
patients than for the general population. However, studies comparing the QoL of ICD patients with
that of patients with other implantable cardiac devices are scarce. We hypothesized that ICD patients
had a poorer QoL than pacemaker patients.
Methods and results All ICD patients living in Iceland at the beginning of 2002 (44 subjects), and a com-
parison group of 81 randomly selected patients with pacemakers were invited to participate. The Ice-
landic Quality of Life Questionnaire (IQL), the General Health Questionnaire (GHQ), the Beck Anxiety
Inventory (BAI), and the Beck Depression Inventory (BDI) were submitted to measure QoL, psychiatric
distress, and symptoms of anxiety and depression. The ICD and pacemaker groups did not differ on
IQL, BAI, BDI, or GHQ scores. ICD patients were as a group more fearful of death (P ¼ 0.056) and
showed more concerns about returning to work (P ¼ 0.072), although these items fell just short of stat-
istical significance.
Conclusion Contrary to our expectations, ICD patients had a comparable QoL with pacemaker recipients
and were not more likely to suffer from anxiety, depression, or general psychiatric distress. These find-









Indications for the use of implantable cardioverter defibril-
lators (ICDs) have been expanding in recent years following
the publications of several large multi-centre trials and now
include preventive implantation for patients with coronary
artery disease and a severely depressed ejection fraction.1–3
This has resulted in increased implantation rates and thus
steadily growing numbers of ICD recipients worldwide.4 At
the same time, concerns remain regarding the quality of
life (QoL) of these patients. Small observational studies
have indicated a poor QoL for ICD patients.5,6 More recently,
a few of the large randomized preventive ICD implantation
and ICD vs. anti-arrhythmic drug trials have evaluated QoL
in subsamples of participants. These have generally shown
a similar or even better QoL among ICD patients not
receiving shocks than patients treated with drugs, but QoL
scores decreasing with increasing numbers of shocks
received from the device.7 ICD recipients commonly report
various physical and psychological symptoms, which
they ascribe to the potentially life-saving cardioverter
defibrillator itself.8,9 The shocks from the ICD are reported
as uncomfortable, are usually unexpected, their timing
unpredictable, and they can occur under any circum-
stances.9 As a consequence, ICD patients frequently report
anxiety, lack of control, and powerlessness.10 Taking these
factors into account, it is quite possible that the device
itself may provoke anxiety and thus result in reduction of
the QoL of ICD patients.
Studies on the QoL of patients with pacemakers, who
served as a control group in our study, indicate a similar
QoL for this patient group to that of patients with other
chronic medical illnesses.11,12 Both ICD patients and pace-
maker patients have an implanted cardiac device, but
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pacemaker patients are less likely to be aware of its
function than ICD patients are of their defibrillator.
In this study, we examined the QoL of ICD patients com-
pared with that of pacemaker patients. We hypothesized,
given the potential of unexpected uncomfortable shocks,
that the ICD group would score higher on subjective
measures of anxiety, depression, and general psychiatric dis-
tress and report a poorer QoL than pacemaker recipients.
Methods
Design
This was a cross-sectional study where all living ICD patients in
Iceland were compared with a group of pacemaker recipients
attending the same outpatient clinic, at the University Hospital in
Reykjavik. The study complied with the Declaration of Helsinki.
Subjects
Following review and approval by the Institutional Review
Committee of Landspitali University Hospital and the Icelandic
Data Protection Commission, a letter of invitation was sent to all
ICD recipients in Iceland who were alive in January 2002. A similar
letter was sent to a randomly selected comparison group of patients
with pacemakers. The letter included information about the aims
and possible benefits of the study, inclusion criteria for research
and control subjects, and contact information if further details
were required. To increase the power of the study and minimize
the risk of age confounding the comparison, we divided both pace-
maker and ICD patients into 10 year age bands and randomly
selected approximately twice as many pacemaker patients as ICD
recipients from each age band, hence broadly but not individually
matching by age. Exclusion criteria included having major mental
or physical disabilities and to be accordingly considered unable to
answer the questionnaires by their caring physicians.
The subjects were offered participation during their next visit to
the outpatient clinic at the University Hospital, but all ICD and the
majority of pacemaker patients in Iceland are seen at this clinic.
The ICD sample is therefore population based and the same
applies to a similar degree to the comparison group.
Measures
We used four different questionnaires to assess anxiety, depression,
psychiatric distress, and health-related QoL. An additional question-
naire was administered to address concerns, which might be of
special relevance to ICD patients.
The Beck Anxiety Inventory (BAI) and The Beck Depression
Inventory (BDI) were formulated by Beck et al.13,14 Each question-
naire consists of 21 questions, which measure self-reported
anxiety and depression.
The General Health Questionnaire (GHQ) is a screening tool to
measure psychiatric distress (an indicator of psychiatric symptoms)
related to general medical illness.15,16 The questionnaire is avail-
able in four versions, differing in length. We used the 30-item
version, which is the version recommended by the authors for
screening purposes.
The Icelandic Quality of Life Questionnaire (IQL) was used to
assess subjects’ perception of their health-related QoL.17,18 This is
a recently developed generic 32-item questionnaire which measures
12 aspects of health-related QoL: general health, cognition,
depression, social functioning, financial status, energy, anxiety,
physical health, self-control, sleep, general well-being, and pain.
It has in recent years been validated and used in a number of
Icelandic studies.17,19
To address additional concerns of particular relevance to ICD
patients, we used the ICD Psychosocial Index—a 14-item question-
naire formulated by McHugh-Schuster et al.20 These authors used
it in their study on QoL issues in ICD patients but have to our knowl-
edge not validated it further. The inventory was translated into
Icelandic and adjusted to our local clinical setting.
After signing an informed consent form, participants were asked
to fill out these five questionnaires before they left the clinic.
Sampling and response rates
A letter of invitation with information about the study was sent to
44 ICD patients and 81 pacemaker patients in the beginning of
2002. ICD patients attend the outpatient clinic on average every 3
months and pacemaker patients on average every 6 months. We
continued to enrol patients into the study for 17 months. One
patient was excluded from the ICD group and three from the pace-
maker group as they met the exclusion criteria. Two ICD patients
and five pacemaker patients did not attend the clinic during the
enrolment period, despite the invitation. Two pacemaker patients
died during the study period.
All 41 ICD patients that attended the outpatient clinic during the
study period accepted the invitation to participate in the study (41/
44 ¼ 93%). Of 71 pacemaker patients who attended the clinic during
the study period, 67 agreed to participate, but 6 patients who were
allowed to complete the questionnaires at home failed to return
them and therefore 61 responses were received (61/81 ¼ 75%).
Power
Power analysis indicated that the study should have .80% power to
identify clinically relevant differences of 35 and 10% of either mod-
erate or severe anxiety scores on the BAI among ICD patients and
the comparison group of twice as many pacemaker recipients,
respectively, at a 5% level of statistical significance. This is based
on the assumption that 85–90% of the invited ICD and pacemaker
patients accepted the offer of participation in the study.
Statistical analysis
All the questionnaires except the ICD Psychosocial Index rely on a
summary of individual question scores rather than a mean score.
In the event of missed answers on the IQL questionnaire, we cor-
rected for such missed answers with mean scores for the relevant
question from the patient’s group as a whole (ICD or pacemaker
patients). In line with authors’ guidelines, missed answers on the
GHQ, BAI, and BDI were given a score of 0. Questionnaires were
excluded from the analysis if a patient failed to answer two or
more questions on the relevant questionnaire.
The x2 test and Student’s t-test were performed to evaluate
differences in demographic data between the two groups. Mean
values for BAI, BDI, and GHQ scores were compared between the
groups using Student’s t-test. Mean values for each aspect of the
IQL and each question in the ICD Psychosocial Index were compared
in the same manner. A conventional level of statistical significance
was used (a ¼ 0.05) and all comparisons were two tailed. Because
of the modest sample size, which limits the study’s power to ident-
ify small or moderate effects, we did not correct for multiple
testing. Results are presented as mean+ standard deviation (SD).
Results
Sample characteristics
Demographic comparisons are presented in Table 1. As
shown in the table, the two groups were comparable and
did not differ significantly with regard to age, sex, marital
status, or occupational status. Time from implantation to
the end of the study period was shorter among the ICD
patients or 37.8+ 28.6 months (range 11.6–154.9 months)
compared with 76.6+ 60.9 months for pacemaker patients
(range 13.4–290.6 months) (P , 0.001).
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As shown in Figure 1, the two groups did not differ signifi-
cantly with regard to self-reported anxiety on the BAI (ICD
patients: 8.0+ 7.8; pacemaker patients: 7.7+ 6.9;
P ¼ 0.819), self-reported depression on the BDI (ICD
patients: 8.7+ 6.3; pacemaker patients: 6.6+ 6.7;
P ¼ 0.121), or overall psychiatric distress on the GHQ (ICD
patients: 5.3+ 5.9; pacemaker patients: 4.1+ 5.3;
P ¼ 0.320). The 12 aspects of the IQL questionnaire did
not show any significant difference between the two
groups (Figure 2).
Some of the questions on the ICD Psychosocial Index
revealed a marked numerical difference between ICD and
pacemaker patients, although this fell just short of statisti-
cal significance (Figure 3). ICD patients expressed, for
instance, more fear of device malfunction (P ¼ 0.084),
more fear of death (P ¼ 0.055), greater concerns about
not being able to work (P ¼ 0.061), more worried about
having sex (P ¼ 0.072), and more worried about driving a
car (P ¼ 0.080). Nineteen of the 41 ICD patients (46.3%)
had received shocks (median number of shocks 3, range
1–43). No statistical differences were found between ICD
patients who had received shocks and those who had not
on any of the inventories.
With the exception of more fear of death, fear of device
malfunction, and fear of shocks on the ICD Psychosocial
index, younger ICD patients (,60 years of age, n ¼ 16)
had better scores on the inventories than older ICD patients
(n ¼ 25). The difference was only statistically significant on
the GHQ (P ¼ 0.002).
Reference values
For the BAI, BDI, GHQ, and IQL, we plotted scores for the
two patient groups against reference values used for these
inventories. As shown in Figure 4, the total score for the
21 questions on the BAI ranges from 0 to 63. User guidelines
refer to scores of 0–9 as minimal anxiety, 10–16 as mild,
17–29 as moderate, and 30–63 as severe anxiety.16 Six of
40 ICD patients who completed the inventory scored 17 or
above (15.0%) and would thus be classified as having moder-
ate or severe anxiety. Seven of the 55 pacemaker patients
completing the questionnaire scored 17 points or more
(12.7%), ranking accordingly as moderately or severely
anxious. Also for the BDI, scores range from 0 to 63 and
are interpreted in the same manner as for the BAI (0–9
minimal depression, 10–16 mild, 17–29 moderate, 30–63
severe depression).16 Four of 41 ICD patients scored 17 or
above (9.8%) on the BDI, as did 2 of the 54 pacemaker
patients (3.7%) who completed the questionnaire (Figure 4).
For the 30-item GHQ, scores range from 0 to 30 using the
GHQ scoring system.16 Patients scoring 5 points or more are
considered probable psychiatric cases. Of 40 ICD patients
completing the questionnaire, 14 scored 5 points or more
(35.0%) and 19 of 57 pacemaker patients would also be clas-
sified as probable psychiatric cases (33.3%) using the same
cut-off (Figure 5). Concerning the IQL Questionnaire, scores
for the two patient groups are compared graphically with
reference values for healthy subjects 50–69-year-old,
retrieved from the authors of the questionnaire (Figure 2).
Discussion
Contrary to our initial hypothesis, no significant differences
were observed between ICD recipients and pacemaker
patients in our nationwide population-based sample on
anxiety, depression, or QoL. Although the ICD Psychosocial
Index did indicate some differences between the two
groups, ICD patients expressed more concerns about death
and more fear of device malfunction and greater concerns
about working, having sex, and driving a car, but these
differences fell just short of statistical significance. These
differences were, however, all in the same direction and
possibly of some clinical relevance.






Mean (SD) 61.8 (14.2) 63.8 (13.1) NS
Range 23–85 19–82
Gender (%)
Male 28 (68.3%) 41 (67.2%) NS




Mean (SD) 37.8 (28.6) 76.6 (60.9) ,0.001
Range 11.6–154.9 13.4–290.6
Marital status (%)
Married 31 (75.6) 41 (68.3%) NS
Divorced 4 (9.8) 7 (11.7%) NS
Single 4 (9.8) 4 (6.7%) NS
Widowed 2 (4.9) 8 (13.3%) NS
Occupation (%)
Working 12 (29.3) 24 (40.7%) NS
Disabled 12 (29.3) 7 (11.9%) NS
Retired 15 (36.6) 24 (40.7%) NS
Student 1 (2.4) 1 (1.7%) NS
Unemployed 0 (0) 1 (1.7%) NS
Domestic work 1 (2.4) 1 (1.7%) NS
Sick leave 0 (0) 1 (1.7%) NS
aTime from implantation of device till the end of the study period.
Figure 1 Scores for ICD and pacemaker patients on the BAI, BDI, and GHQ.
No significant differences were found between the groups on any of the
inventories.
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The main strength of this study is the fact that it was
population based and very high recruitment was attained
for the ICD group, 93% of all living ICD recipients in
Iceland taking part. Furthermore, several instruments
were used to measure anxiety, depressive symptoms,
general psychiatric distress, QoL, and concerns of particular
relevance to patients with implanted cardiac devices.
Limitations
The present study had several limitations. First, and
perhaps most significantly, the size of the study was
modest. This limits the power to identify small- and
medium-sized effects. Second, the response rate was some-
what lower in the pacemaker group (75 vs. 93%) and ques-
tions not answered were also more frequent in that group.
This might partly be explained by the fact that the study
was designed to evaluate anxiety, depression, and QoL
among ICD patients, and as a result, the pacemaker group
might not have been enthusiastic about participation.
Third, we did not record underlying cardiac illnesses and
co-morbidity for the patients, so any such differences
between the two groups are unrevealed. For the same
Figure 2 Outcome from the IQL. Unlike the BAI, BDI, GHQ, and ICD Psychosocial Index, the lower the score on the IQL, the worse the outcome. No significant
differences were observed between ICD patients and pacemaker carriers on any of the 12 domains of the IQL. Comparisons with normal population values (age
band 50–69 years) are shown.
Figure 3 Outcome from the ICD Psychosocial Index. No items revealed a statistical difference between the two groups in our relatively modest sample.
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reason, the extent to which the underlying cardiac illness
rather than the device itself affects QoL of the patients
remains unknown. Other differences between the two
study groups, such as circumstances leading to device
implantation, age at implantation, time from implantation
to conduction of the study, and the mere size of device
implanted, may also be confounding factors. Fourth, the
relatively low incidence of shocks received in the ICD
group might partly explain the lack of difference
between the two groups, but previous studies have
indicated that it may affect the psychological well-being
of ICD recipients.21–24 Fifth, the fact that all of the
measurements used in this study, apart from the ICD
Psychosocial Index, are well known and widely used
generic measures and not disease specific, could have
affected the observed outcome. The use of such generic
measures will, though, facilitate comparisons with other
patient groups.
Anxiety
Most studies examining psychological disorders among ICD
patients agree on anxiety being the one most commonly
encountered in this patient group, with diagnostic rates
for clinically significant anxiety ranging from 13 to 38%.5,25
To our knowledge, only one study has previously been pub-
lished, which compares QoL and signs of affective disorders
between pacemaker and ICD patients. Duru et al.26 evalu-
ated QoL and signs of anxiety and depression in 76 patients
with ICDs, compared with 76 patients with pacemakers in a
recent paper. Probable anxiety disorder was encountered in
13.1, 9.7, and 13.3% of the pacemaker, non-shocked, and
shocked ICD patient groups, respectively.26 This is similar
to the findings in our study, where 15.0% of the ICD patients
and 12.7% of the pacemaker patients would be classified as
having moderate or severe anxiety by means of their BAI
scores. These relatively low percentages, compared with
previous studies, might be partly explained by the fact
that ICD technology has improved considerably over the
last 10 years, with more arrhythmias being terminated by
anti-tachycardia pacing techniques, resulting in fewer
shocks actually being felt by the patients.27
Depression
A recent study by Ruo et al.,28 on QoL among patients with
coronary artery disease, showed that depression is a stron-
ger indicator of poor QoL among this patient population
than physiological measures of cardiac function, such as
ejection fraction. In their study, 20% of the patient popu-
lation had symptoms of major depression. In another study
on depressive symptoms among patients with coronary
artery disease, 12% showed signs of moderate or severe
depression by means of the BDI, at 18 months after myo-
cardial infarction.29 In our study, 9.8% of the ICD patients
and 3.7% of the pacemaker patients met cut-off levels for
moderate or severe depression by means of the BDI.
Probable depressive disorder observed in the study of Duru
et al.26 were even lower, with 5.2% of the pacemaker
patients and 6.5% ICD patients suffering from depression.
Quality of life
Originally, studies on QoL among ICD patients were mostly
observational studies of limited size with no comparative
groups.6 More recently, QoL data have been emerging from
the large randomized preventive ICD implantation and ICD
vs. anti-arrhythmic drug trials, where QoL has been evalu-
ated in subsamples of the patient populations and compared
with medically treated patients.7 Duru et al. evaluated QoL
in their paper, with the ICD patients further divided into two
groups, depending on whether they had received shocks. As
in our study, no significant differences were observed on
measurements of QoL between the two groups.
It may be the case that in spite of the ICD’s ability to
produce uncomfortable and unpredictable shocks, ICD
patients are relatively positive towards their devices,
because of their life-saving quality.6 This might affect ICD
patients’ overall perspective and subjective QoL and
nurture optimism, despite the seriousness of the underlying
disease.
Even though QoL as a whole was not significantly different
between our patient groups, various aspects of daily life,
Figure 4 Score distributions for ICD and pacemaker patients on the BAI and
BDI. According to reference values, patients scoring 17 points or more would
be considered as having moderate or severe anxiety/depression. ICD, ICD
patients; PM, pacemaker patients.
Figure 5 Score distributions for ICD and pacemaker patients on the
GHQ, viewed against reference values. Subjects scoring 5 points or
more are considered probable psychiatric cases. 35.0 and 33.3% of the
ICD and pacemaker patients, respectively, scored 5 points or more
(P ¼ NS).
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affecting ICD patients’ ability to adapt socially, seem to be
of concern to this patient group. The ICD patients expressed
somewhat more concerns about activities such as driving a
car and having sex, about device malfunction, and about
dying, with differences between the groups falling just
short of statistical significance but being in the same direc-
tion for all items. This may not be surprising, because the
ICD is literally a life-saving device and thus the possible con-
sequences of device malfunction would be expected to be
more distressing than for pacemaker patients. The unpre-
dictability and discomfort of shocks are also probably an
important contributing factor when considering concerns
about driving a car and having sex. Studies have also
shown that the recommended abstinence from driving
after ICD implantation is very distressing for many ICD
patients, as it hampers their ability to return to previous
routines in their life.30
The observed difference between our two study groups and
the normal population reference values on ‘energy’ and
‘general health’ aspects of the IQL questionnaire (Figure 2)
is probably explained by the fact that the reference values
are based on largely healthy individuals as opposed to individ-
uals often with severe medical illnesses in our study groups.
Conclusions about this difference must be drawn with some
caution, because the populations also differ in other
aspects, including age and sex to some degree.
ICD patients receiving shocks vs. those not having
received a shock
When reviewing the literature, the majority of studies com-
paring QoL for shocked vs. non-shocked ICD patients reports
a worse outcome for shocked ICD patients.21–24 The AVID
Trial (Antiarrythmics Versus Implantable Defibrillators
Trial), CIDS (Canadian Implantable Defibrillator Study), and
CABG Patch Trial research groups all reported either a
stable or declining QoL for shocked ICD-patients over a 12
month follow-up period after ICD implantation, compared
with that for non-shocked patients, with sample sizes
ranging from 317 to 905 patients.21–23 In our sample of 41
ICD patients, however, no statistical differences were
observed on any of the questionnaires administered
between shocked and non-shocked ICD patients. The risk
of type II error has to be kept in mind when making such sub-
group comparisons.
General psychiatric distress
Approximately 35% of both our patient groups showed signs
of general psychiatric distress by means of the GHQ. This is
compatible with psychiatric symptoms detected among
patients seeking primary care.31,32 Previous studies have
shown that administering relatively simple measurement
tools such as the GHQ can help to detect psychological
symptoms that may otherwise not reach diagnostic
thresholds, but which are associated with an increased risk
of later developing psychiatric illness and disability.32,33
Future implications
Earlier studies and our own study indicate that both ICD
patient and pacemaker patient populations include individ-
uals at high risk of developing common mental disorders.
To which extent the device itself, on one hand, and the
underlying cardiac illnesses, on the other hand, play a role
remains unanswered. Either way, it is necessary for health-
care personnel to be aware of signs and symptoms of
anxiety and depression when attending to these patients.
Preventive measures are also very important, with adequate
patient education and awareness, support groups for
patients, and family members having shown beneficial
results for their psychological well-being.34,35 We are there-
fore pleased to report that in the wake of this study, an ICD
patient support network was set up among ICD patients in
Iceland.
The fact that the ICD patients in our study expressed
somewhat more concerns about specific activities such as
driving a car and having sex, about device malfunction,
and about dying raises the question whether this patient
group might need a more standardized approach to
prepare them for life with a defibrillator. A randomized con-
trolled trial on whether specified patient education prior to
implantation of an ICD might help to reduce these concerns
is a highly relevant topic for further research.
Conclusions
Our study indicates that health-related QoL appears to be
similar among ICD patients and pacemaker recipients. This
is of importance in the light of the expanding use of ICDs
in patients with coronary artery disease and a decreased
ejection fraction. Nevertheless, individuals are found
among both ICD and pacemaker patients who seem to
suffer substantially from anxiety or depression. This study
therefore supports the suggestions set out by others28 that
psychiatric co-morbidity is prevalent and perhaps more
important among cardiac patients than previously acknowl-
edged. Medical personnel attending these patients need to
be aware of signs and symptoms of psychological distress
and react to the patients’ needs accordingly. More infor-
mation prior to device implantation, improved access to
psychiatric care resources during follow-up, and patient
support groups might help to meet those needs. As a conse-
quence, such resources could help to improve the health-
related QoL of these patient groups.
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